Pretreatment SUVmax as a Marker for Progression-Free Survival in Stage I NSCLC Treated With SBRT.

Cite this paper

@article{Horne2013PretreatmentSA, title={Pretreatment SUVmax as a Marker for Progression-Free Survival in Stage I NSCLC Treated With SBRT.}, author={Zachary Horne and David Andy Clump and S. Shah and John A Vargo and Stephanie A Burton and Nanette Christie and Megan Schuchert and Rodney J. Landreneau and J. D. Luketich and Dwight Earl Heron}, journal={Practical radiation oncology}, year={2013}, volume={3 2 Suppl 1}, pages={S3-4} }